Combined Blockade of VEGFR-3 and VLA-1 to Improve Transplant Survival
90% graft survival local or systemic administration demonstrated in mouse model
corneal transplants in low-risk and high-risk settings corneal vascularization in various diseases other tissue or organ transplant other immune- or lymphatic-related disorders e.g. cancer metastasis
None
Patent Number: US20150102907A1
Application Number: US14050742A
Inventor: Hadizad, Peyman
Priority Date: 10 Oct 2013
Priority Number: US20150102907A1
Application Date: 10 Oct 2013
Publication Date: 16 Apr 2015
IPC Current: G07C000900 | G08C001702
US Class: 34000564
Assignee Applicant: Motorola Mobility LLC,Libertyville | Motorola Mobility LLC,Libertyville
Title: Method and System for Controlling Access to a Restricted Location
Usefulness: Method and System for Controlling Access to a Restricted Location
Summary: Method for controlling physical access to a restricted location through wireless medium e.g. Near Field Communication (NFC) medium, a personal area network (PAN) medium, and a local area network (LAN) medium, and visual image such as an alphanumeric code, a visual representation of an object, a visual representation of a person, a pattern, a bar code, and a quick response (QR) code (all claimed).
Novelty: Method for controlling physical access to restricted location through wireless medium e.g. near field communication and visual representation of object, involves determining whether to grant access to restricted location
Robot/Machinery
9364535
Related Materials Combined Blockade of VEGFR-3 and VLA-1 Markedly Promotes High-Risk Corneal Transplant Survival Additional Technologies by these Inventors Tech ID/UC Case 22498/2012-097-0 Related Cases 2012-097-0
USA
